Navigation Links
Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Date:7/26/2013

nded periods of time.

Data from Intarcia's ITCA 650 Phase 2 program have demonstrated significant and sustained reductions in HbA1c and body weight over 48 weeks of treatment with a marked reduction in the GI adverse events typically associated with the self-injection products in this class. ITCA 650 is an investigational new therapy and is not currently approved by any regulatory authority. Exenatide, the active agent in ITCA 650, is a glucagon-like peptide-1 (GLP-1) receptor agonist currently marketed globally as twice-daily and once-weekly self-injection therapies for type 2 diabetes. Upon approval, ITCA 650 would represent the first injection-free GLP-1 therapy that can deliver a full year of treatment from a single minipump placement. Intarcia's robust intellectual property portfolio protects ITCA 650 through 2031.

About Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. is a biopharmaceutical company developing therapies to enhance treatment outcomes by optimizing and improving the efficacy, continuous administration and tolerability of drug therapies. In addition, delivering medicines just once or twice yearly virtually ensures patient adherence and compliance, which is very poor in most chronic diseases. Intarcia's drug development expertise and competitive edge are demonstrated by its abilities to stabilize proteins and peptides at above-body temperature and to deliver them in a constant and consistent manner via Intarcia's proprietary technology platform. Intarcia is pursuing a Phase 3-stage development program for type 2 diabetes and has additional programs ongoing for weight regulation to control obesity. For more information on the Company, please visit www.intarcia.com.

Intarcia and its logo are registered trademarks of Intarcia Therapeutics, Inc.


'/>"/>
SOURCE Intarcia Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
2. Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
3. Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
4. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
5. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
6. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
9. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... , April 28, 2015 Konica ... achieved record sales growth for fiscal year ended ... digital radiography family of Primary Imaging Solutions.  The ... fueled company growth to double digit sales figures ... solutions includes the AeroDR XE, a wireless flat ...
(Date:4/28/2015)... 28, 2015  nUro, Inc. (the "Company") announced ... invest in Rosellini Scientific Benelux, SPRL. This marks the ... equity injections and one acquisition). nUro, Inc. plans to ... rapid prototyping labs in Wallonia and in conjunction ... investment comes in conjunction with notice of an ...
(Date:4/28/2015)... BIRMINGHAM, Ala. , April 28, 2015 /PRNewswire/ ... solution company for quickly and accurately capturing complete ... introduces the rebranding of its software platform to ... learns and simplifies what surgeons need to successfully ... unreasonable and unacceptable burden on surgeons to micro-dictate ...
Breaking Medicine Technology:Konica Minolta Sets Record Digital Radiography Sales 2nUro, Inc. Invests in Wallonia-Based Medtech Company 2nUro, Inc. Invests in Wallonia-Based Medtech Company 3nUro, Inc. Invests in Wallonia-Based Medtech Company 4Vincari introduces Lightspeed Valet, a web and mobile software solution for delivering ICD-10 surgical documentation at the point-of-care with extreme speed and accuracy 2
... 3, 2011 Clinicians may soon have a new tool ... – one of the most common sexually transmitted infections in ... and Company) (NYSE: BDX ), announced today that ... clearance for the first fully automated molecular tests to diagnose ...
... 2011 See video from Endo Pharmaceuticals at: ... The FDA has approved Fortesta™ (testosterone) ... low testosterone or "Low T," a condition that ... States. Available content includes an audio news release, ...
Cached Medicine Technology:New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients 2
(Date:4/28/2015)... April 28, 2015 Aultman Hospital ... Advantage (WCA) to transition its outpatient wound center ... hospital’s commitment to the specialty of wound care ... the country currently working with Wound Care ... advanced wound care treatments and hyperbaric oxygen therapy ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Consolidated ... are moving forward nationwide, as courts overseeing proceedings ... next month. According to court documents issued in ... the next status conference in the federal Xarelto ... 9:00 a.m. C.S.T. (In Re: Xarelto Products ...
(Date:4/28/2015)... Orange, N.J. (PRWEB) April 28, 2015 Seton ... of Kathleen M. Boozang as the new Dean of Seton ... Dean effective July 1, 2015. , Boozang, currently Associate ... Hall Law in 1990. She helped launch and currently ... Law & Policy, ranked a Top 10 law health ...
(Date:4/28/2015)... April 28, 2015 April 8th, ... Debbie Durkin’s “RockNRolla Movie Awards” EcoLuxe Lounge, with ... event. Durkin Entertainment, Los Angeles’ leading producer of ... the organizing force behind this event, which featured ... and socially conscious products and services. The EcoLuxe ...
(Date:4/28/2015)... April 28, 2015 Children’s Medical ... the cause of medical foods and formulas through ... as the organization’s new executive director. , Thousands ... health consequences because of conditions and diseases that ... diet. To live and thrive, they are ...
Breaking Medicine News(10 mins):Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 2Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 3Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 3Health News:Seton Hall University Announces Kathleen M. Boozang as New Dean for Law School 2Health News:Seton Hall University Announces Kathleen M. Boozang as New Dean for Law School 3Health News:Choices Recovery South Bend Examines Support Systems in Treatment with Hollywood's Mike Pericoloso 2Health News:Children's Medical Nutrition Alliance (CMNuA) Hires Kaycee Childress as Executive Director 2
... experience their dark moods in an on-again, off-again,fashion. In ... the oscillations follow a seasonal schedule, with the depression,usually ... Lack of light,is often blamed for SAD, but just ... in question, reports the January 2008 issue of the,Harvard ...
... Marks a New Era for Casino Patrons and Employees, ... Jan. 1, 2008, employees,and visitors at Colorado casinos will ... will be completely smoke-free to comply with the,Colorado Clean ... will,protect casino employees and guests from exposure to secondhand ...
... Noncombat-related acute and recurrent chronic pain are the leading causes ... as low as 2 percent when these soldiers are treated ... 95 percent when troops and officers are treated and managed ... elsewhere for therapy, according to a new study from a ...
... without diet changes, study finds , , MONDAY, Dec. 17 (HealthDay ... week is enough to undo metabolic syndrome, a health condition ... new study suggests. , "What we found was a modest ... metabolic syndrome risk," said study author Johanna L. Johnson, a ...
... John P. Murtha, Chairman of the House Appropriations Subcommittee on ... behalf of veterans blinded by war and for research to ... the Institute gives the Man of Vision Award to an ... the awareness of the challenges of vision loss. Among previous ...
... effort to help,prepare today,s students to become ... Nations Environment Programme,s North American,Regional Office (UNEP ... Day,partnership and launched the International Children,s Painting ... Children,s Painting Competition (ICPC) invites,elementary and middle ...
Cached Medicine News:Health News:Lack of Light and Seasonal Depression - What's the Link? From the Harvard Health Letter 2Health News:Colorado Casinos Clear the Air and Become Smoke-Free in 2008 2Health News:Colorado Casinos Clear the Air and Become Smoke-Free in 2008 3Health News:Pain treatment in the field: Good for soldiers' comfort and better for rebuilding troop strength 2Health News:Moderate Exercise Cuts Risk of Metabolic Syndrome 2Health News:Moderate Exercise Cuts Risk of Metabolic Syndrome 3Health News:Champion of blinded soldiers, Congressman Murtha, is Man of Vision 2Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools 2Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools 3Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools 4
Substrate Plasma for Factor VII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VII has been removed by selective immuno-adsorption....
Immuno-turbidimetric Assay of von Willebrand Factor (vWF) Antigen by STA© Analyzers. Microlatex particles coated with rabbit anti-human vWF antibodies....
Colorimetric Assay of Antiplasmin Activity by STA© Analyzers...
HbA1c / HbCalibrator...
Medicine Products: